Egyptian International Pharmaceutical Industries Co. (PHAR) Key Statistics
26 reported figures for Egyptian International Pharmaceutical Industries Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 21.47B
- P/E (trailing)
- 13.79
- P/B
- 3.43
- Dividend yield
- 2.75%
Income (latest fiscal year)
- Revenue
- EGP 9.44B
- Net income
- EGP 1.44B
- EBITDA
- EGP 2.46B
- Free cash flow
- EGP -109.98M
- Profit margin
- 15.27%
Balance sheet
- Total assets
- EGP 18.27B
- Total debt
- EGP 8.81B
- Book value
- EGP 6.53B
Growth
- Revenue growth
- 24.38%
- Profit growth
- 31.57%
- EPS growth
- 20.8%
Per share
- EPS (fiscal year)
- 8.9
- Book value per share
- 37
- Dividend per share
- 3.5
- Return on equity
- 26.46%
- Return on assets
- 8.57%
Technical
- RSI (14)
- 50.2
- 50-day moving average
- EGP 115.54
- 200-day moving average
- EGP 89.36
- Beta (1Y)
- 0.38
Shares
- Shares outstanding
- 168.76M
- Free float
- 31.64%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.